LakeShore Biopharma Co Total Liabilities

LakeShore Biopharma Co (YS) currently reports a total liabilities of $870M as of March 2025. That compares with $930M in the prior-year period — down 6.5% year over year. Use the charts on this page to explore LakeShore Biopharma Co's total liabilities history and peer comparisons.

LakeShore Biopharma Co's total liabilities decreased from $930M to $870M — a 6.5% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LakeShore Biopharma Co reported $870M in total liabilities as of March 2025. That compares with $930M in the prior-year period — down 6.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $870M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following YS for alerts when major investors trade the stock.